Clarification - agreement for orthopaedic products in HK
Filed with ASX · · 4 pages · English
Australian-Singaporean regenerative medicine company Osteopore Limited (ASX: OSX; Osteopore or Company) – a global leader in 3D-printed biomimetic and bioresorbable implants – would like to provide clarification details relating to its exclusive agreement with MontsMed Hong Kong Company Limited (MontsMed) for the introduction of its custom and off-the-shelf orthopaedic products into Hong Kong. The
Earlier from Osteopore
- OSX strikes agreement for orthopaedic products in Hong Kong
- Clarification - OSX partner Chinese dental & maxillofacial
- OSX partners up for Chinese dental & maxillofacial market
- OSX partners DKSH for dental products in Malaysia
- Activities Report September 2025 and Appendix 4C
Later from Osteopore
- Activities Report December 2025 and Appendix 4C
- Further Drawdown of T1 of the Redeemable Convertible Notes
- Osteopore Secures Latin America Deal For Craniofacial Distribution
- OSX secures Latin America deal for craniofacial distribution
- Drawdown of Tranche 2 of the Redeemable Convertible Notes
Follow Osteopore into a list and get an email when it puts out news.
Follow Osteopore